Literature DB >> 12456633

Subsidized IVF: the development of 'egg sharing' in the United Kingdom.

E Blyth1.   

Abstract

Egg sharing is an arrangement in which a woman is offered free or reduced-cost assisted conception treatment in return for 'donating' oocytes for the treatment of another woman, the cost of her treatment being subsidized by the recipient of her oocytes. Egg sharing has been developed for a variety of reasons: to ameliorate donor oocyte shortages, to avoid potential health risks to non-patient donors and, given the limited availability of publicly funded assisted conception treatment in the UK, to make treatment more readily available to individuals on lower incomes, thus expediting treatment by reducing waiting lists. This paper outlines the development and current status of egg sharing in the UK through analysis of responses to a consultation on payment to gamete donors initiated by the Human Fertilisation and Embryology Authority (HFEA) and the HFEA's Guidance for Egg Sharing Arrangements.

Entities:  

Keywords:  Genetics and Reproduction; Human Fertilisation and Embryology Authority

Mesh:

Year:  2002        PMID: 12456633     DOI: 10.1093/humrep/17.12.3254

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  4 in total

1.  A shared egg donor program: which is the minimum number of oocytes to be allocated?

Authors:  Demian Glujovsky; Marcelo Dominguez; Gabriel Fiszbajn; Sergio Papier; Mariano Lavolpe; Carlos Sueldo
Journal:  J Assist Reprod Genet       Date:  2010-11-19       Impact factor: 3.412

2.  Should there be a female age limit on public funding for assisted reproductive technology?

Authors:  Drew Carter; Amber M Watt; Annette Braunack-Mayer; Adam G Elshaug; John R Moss; Janet E Hiller
Journal:  J Bioeth Inq       Date:  2013-01-04       Impact factor: 1.352

3.  Human therapeutic cloning (NTSC): applying research from mammalian reproductive cloning.

Authors:  Andrew J French; Samuel H Wood; Alan O Trounson
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

4.  Is It Possible to Expand Oocyte Donors by Decreasing Number of Oocytes for Own Use? Insights From a Large Single-Center Study.

Authors:  Zhiqin Bu; Jiaxin Zhang; Yile Zhang; Yingpu Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-11       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.